Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial
about
Helminth infections: the great neglected tropical diseasesEbola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.New parenteral anticoagulants in development.In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa.Discovery methodology for the development of direct factor VIIa inhibitors.New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesTherapeutic immunomodulators from nematode parasites.Recent advances in oral anticoagulation for atrial fibrillation.The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises.Toxins in thrombosis and haemostasis: potential beyond imagination.Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.Investigational anticoagulants for hematological conditions: a new generation of therapies.Contemporary anticoagulation therapy in patients undergoing percutaneous intervention.Recombinant nematode anticoagulant protein c2 in non-ST segment elevation acute coronary syndrome and beyond.Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.
P2860
Q24648324-BCC8E58A-07B2-47A3-8B61-4980DC449154Q30251949-3B0640E6-09B0-4D66-AECF-CC81742428E9Q33392647-D953D5EC-E761-401A-8280-F33AAC900A01Q34782370-78EA864D-011D-4B76-886F-C87CF5D89C05Q35177353-DC05C785-A1F4-4C60-9410-324AADA3311DQ35752611-349CBECA-282D-4518-AA7F-F5A5DD86483FQ37194019-EBE1D524-71E5-49E0-BDF7-DEA29A903699Q37802084-6E5E44D6-2ED4-41EC-86CA-8B2060B84FAFQ37808230-B4BDA7E9-78ED-4FDF-8241-198FB9632D83Q37827882-289DAE6B-980E-4E2B-BAB3-FFEFFBAEC36AQ37903941-52440B46-1510-47F8-BF97-4F67A83E54A7Q38043676-1FE73452-9E07-4EFB-9E7B-DE8121B8770AQ38123237-0E467DE2-19F4-433E-96FB-AD32888C1DD4Q38186094-626B0634-0328-4B6D-B478-5F16969ED8F5Q40199253-77E35518-7155-4866-9D3B-4D7C99391B20Q46456694-6BD31964-4D5D-4C44-A910-C753B3F814DDQ53564169-CD690877-4FFE-4340-B129-4CA0458E479F
P2860
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@ast
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@en
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@nl
type
label
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@ast
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@en
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@nl
prefLabel
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@ast
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@en
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@nl
P2093
P1476
Recombinant nematode anticoagu ...... rome: the ANTHEM-TIMI-32 trial
@en
P2093
Alain Bouchard
Carolyn H McCabe
Daniel I Simon
Marc J Schweiger
Massoud A Leesar
Michael A Goulder
Peter H Stone
Stephen D Wiviott
Steven R Deitcher
P304
P356
10.1016/J.JACC.2007.02.065
P407
P577
2007-06-26T00:00:00Z